Tuesday, May 01, 2007 11:06:48 AM
http://www.balchem.com/core/newsletter_details.asp?ArticleID=323
Balchem Completes Acquisition of Akzo Nobel’s European-based Choline Chloride and Methylamines Businesses at Marano Ticino, Italy
New Hampton, New York. May 1, 2007. Balchem Corporation (NASDAQ:BCPC) today announced the completion of its acquisition of the European-based choline chloride and methylamines businesses of Akzo Nobel Chemicals S.p.A. in Marano Ticino. Balchem and Akzo Nobel originally announced this acquisition on April 2, 2007. This facility and business will be operated by Balchem Italia, S.r.l. and employs approximately 75 people in Marano Ticino. In addition, a three person sales force operating out of Balchem Trading B.V. in the Netherlands will have primary responsibility for the marketing, sales and distribution of certain products produced at the facility. In 2006, the Akzo Nobel Marano Ticino business had approximately $35 million dollars (U.S.) in sales.
Balchem is a worldwide leader in the production and sales of various choline chloride products, which are nutritional additives to animal feed and human food products. Methylamines are a primary building block for the manufacture of choline products and have several other chemical applications.
Dino Rossi, Balchem’s President, CEO and Chairman added, “The closing of this transaction marks a tremendous step forward in the evolution and growth of Balchem. This acquisition provides a direct platform for Balchem to meet the growing market needs of methylamines, choline chloride and derivative products for customers via improved global sourcing, regulatory support, marketing and distribution capabilities.”
For more details regarding the closing of this transaction, including the provisional purchase price, see Balchem's Form 8-K filing to be submitted to US Securities and Exchange Commission (www.sec.gov).
Your trading and investment choices should be the result of your own due diligence.
Recent BCPC News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:15:19 PM
- Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024 • GlobeNewswire Inc. • 08/23/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 10:08:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 10:09:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/31/2024 08:30:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/30/2024 08:05:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 09:22:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/26/2024 08:47:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 11:07:51 AM
- Balchem Corporation Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/26/2024 11:00:00 AM
- Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 26, 2024 • GlobeNewswire Inc. • 07/12/2024 11:00:00 AM
- Balchem Corporation to Present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024 • GlobeNewswire Inc. • 06/26/2024 11:00:00 AM
- Form 11-K - Annual report of employee stock purchase, savings and similar plans • Edgar (US Regulatory) • 06/18/2024 06:59:37 PM
- Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024 • GlobeNewswire Inc. • 05/29/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/24/2024 10:01:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2024 08:13:13 PM
- Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024 • GlobeNewswire Inc. • 05/21/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:15:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 09:16:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 08:15:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 08:09:23 PM
- Balchem Corporation Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- New York Jets Announce Multi-Year Partnership with VitaCholine® • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Balchem Corporation to Attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024 • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Balchem Corporation Releases 2023 Sustainability Report • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM